3r8h: Difference between revisions
Jump to navigation
Jump to search
New page: '''Unreleased structure''' The entry 3r8h is ON HOLD Authors: Yosaatmadja, Y., Teague, R.M., Flanagan, J.U., Squire, C.J. Description: AKR1C3 complex with zomepirac |
No edit summary |
||
| (8 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==AKR1C3 complex with zomepirac== | |||
<StructureSection load='3r8h' size='340' side='right'caption='[[3r8h]], [[Resolution|resolution]] 1.90Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[3r8h]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3R8H OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3R8H FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=NAP:NADP+NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NAP</scene>, <scene name='pdbligand=ZOM:[5-(4-CHLOROBENZOYL)-1,4-DIMETHYL-1H-PYRROL-2-YL]ACETIC+ACID'>ZOM</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3r8h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3r8h OCA], [https://pdbe.org/3r8h PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3r8h RCSB], [https://www.ebi.ac.uk/pdbsum/3r8h PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3r8h ProSAT]</span></td></tr> | |||
</table> | |||
== Function == | |||
[https://www.uniprot.org/uniprot/AK1C3_HUMAN AK1C3_HUMAN] Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ) and the oxidation of 9-alpha,11-beta-PGF2 to PGD2. Functions as a bi-directional 3-alpha-, 17-beta- and 20-alpha HSD. Can interconvert active androgens, estrogens and progestins with their cognate inactive metabolites. Preferentially transforms androstenedione (4-dione) to testosterone. | |||
==See Also== | |||
*[[Prostaglandin F synthase 3D structures|Prostaglandin F synthase 3D structures]] | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Homo sapiens]] | |||
[[Category: Large Structures]] | |||
[[Category: Flanagan JU]] | |||
[[Category: Squire CJ]] | |||
[[Category: Teague RM]] | |||
[[Category: Yosaatmadja Y]] | |||
Latest revision as of 15:14, 14 March 2024
AKR1C3 complex with zomepiracAKR1C3 complex with zomepirac
Structural highlights
FunctionAK1C3_HUMAN Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ) and the oxidation of 9-alpha,11-beta-PGF2 to PGD2. Functions as a bi-directional 3-alpha-, 17-beta- and 20-alpha HSD. Can interconvert active androgens, estrogens and progestins with their cognate inactive metabolites. Preferentially transforms androstenedione (4-dione) to testosterone. See Also |
| ||||||||||||||||||